ANTHONY J. COMEROTA, M.D.

Plain English
This study looked at the shape of veins treated with stents in patients suffering from blockages in the iliofemoral veins, which are found in the leg. Researchers found that after stents were placed, the size of the vein openings increased, but the overall shape changed from more circular to less circular; this was measured as the aspect ratio, which went from 2.0 before the stent to 1.4 afterward. Importantly, while these changes in shape and size were observed, they did not appear to affect the overall improvement in patients' symptoms after one year. Who this helps: This helps patients with iliofemoral vein blockages who are undergoing stent placement.

Plain English
This study looked at how different treatments for deep vein thrombosis (DVT), a condition that affects over 350,000 people annually in the U.S., impact the chances of patients needing to return to the hospital within 30 days. Researchers found that 14.7% of patients were rehospitalized within a month. Using a procedure called catheter-directed thrombolysis (CDT) reduced the risk of readmission, while patients who had a vena cava filter placed ended up with higher chances of being readmitted. Who this helps: This benefits patients with deep vein thrombosis and their healthcare providers.

Plain English
This study looked at the Zilver Vena venous stent to see how safe and effective it is for treating patients with blocked veins in the leg. Researchers found that 96.7% of patients experienced no major complications within 30 days after the procedure, and 89.9% of the stents remained open after 12 months, which is better than previously expected. Additionally, patients reported a significant decrease in their symptoms over the year, showcasing the stent’s positive impact on their quality of life. Who this helps: This helps patients suffering from venous blockages in their legs.

Plain English
This study examined the effects of a treatment called pharmacomechanical catheter-directed thrombolysis (PM-CDT) on blockages in the branches of the pulmonary arteries in patients with acute pulmonary embolism. Researchers found that after 48 hours of treatment, the number of segmental artery blockages dropped dramatically from 40.5% to 11.7%, and for proximal artery blockages, it fell from 28.7% to 11.0%, showing that the treatment is very effective (<0.0001). This is important because reducing these blockages can significantly improve patient health and lower the risk of death. Who this helps: This helps patients with acute pulmonary embolism.

Plain English
This study looked at how well a combined treatment of endovenous laser ablation (EVLA) and foam sclerotherapy works for treating problems in the great saphenous vein, which is important for people with chronic venous disease. Out of 246 limbs treated, 93% achieved complete closure of the vein, showing that this combined approach is very effective. It is important because it has a high success rate with few complications, making it a good option for patients suffering from venous issues. Who this helps: Patients with chronic venous disease.

Plain English
This study looked at different treatment options for nonembolic acute limb ischemia (ALI), a condition where blood flow to the limbs is suddenly reduced. Researchers analyzed data from 205 patients treated at hospitals in Northwest Ohio between 2009 and 2012. They found that surgery was the least expensive option at about $17,163, providing 17.25 life years, while endovascular treatment was the most cost-effective overall, costing around $20,620 and providing 18 life years, confirming its value for healthcare spending. Who this helps: This helps patients suffering from ALI, as well as doctors deciding on treatment options.

Plain English
This study looked at how a treatment called Micronized Purified Flavonoid Fraction (MPFF), derived from orange peels, helps patients with chronic venous disease heal ulcers and reduce symptoms like swelling. After reviewing 250 studies, researchers found that MPFF can provide positive results without serious side effects, supporting its use alongside compression therapy. This is important because MPFF offers a safe and effective option for managing chronic venous disease in patients. Who this helps: Patients suffering from chronic venous disease.

Plain English
This study looked at a treatment called VM202, which uses a type of DNA to promote blood vessel growth in patients with critical limb ischemia (CLI), a severe condition that can lead to amputation. In a trial with 52 patients, those receiving the high dose of VM202 had significantly better outcomes, with 8 out of 13 ulcers healing completely compared to just 1 out of 9 in the placebo group. Additionally, the high-dose group showed better blood flow measures after 12 months, indicating that VM202 is safe and may help improve healing and blood circulation in these patients. Who this helps: This benefits patients suffering from critical limb ischemia.

Plain English
This research paper focuses on how to manage patients with peripheral arterial disease (PAD), a condition that increases the risk of heart and brain problems. It highlights that smoking and diabetes are the leading risk factors for PAD and emphasizes the importance of preventive treatments similar to those used for coronary artery disease. Key findings include the recommendation for almost all PAD patients to take antiplatelet medications, with aspirin being the first choice, and the need for managing cholesterol and blood pressure to lower the risks of serious cardiovascular events. Who this helps: This helps patients with peripheral arterial disease and their doctors.

Plain English
This study examined how a gene called Tlr9 affects the body's response to deep vein thrombosis (DVT), a condition where blood clots form in the veins. Researchers found that mice without the Tlr9 gene had larger blood clots and slower resolution of the condition compared to regular mice, with the clot size being greater even after 21 days (though no extra scarring in the vein walls was noted). Understanding Tlr9's role in inflammation could lead to new ways to treat DVT without relying solely on blood thinners. Who this helps: This research benefits patients at risk for or suffering from DVT.

Plain English
This study looked at how the number of catheter-directed thrombolysis (CDT) procedures performed at hospitals affects the health outcomes of patients with serious blood clots in their legs. Researchers found that patients treated at high-volume hospitals (those that perform six or more CDT procedures a year) had lower death rates (0.6%) compared to those at low-volume hospitals (1.5%). This matters because it suggests that hospitals with more experience in performing this procedure can achieve better outcomes for patients. Who this helps: This helps patients with acute deep vein thrombosis who need treatment.

Plain English
This research paper looks at how venous ulcers develop, focusing on high blood pressure in the veins as the main cause. It was found that various factors, including genetics, can worsen this condition and lead to severe skin problems known as venous leg ulcers if not properly treated. Understanding this process is crucial as it lays the groundwork for better prevention and treatment strategies in the future. Who this helps: This helps patients with chronic venous diseases and their doctors.

Plain English
Researchers examined how a specific cell receptor, CCR7, affects vein wall damage after deep vein thrombosis (DVT), a condition that can lead to post-thrombotic syndrome. They found that mice lacking CCR7 showed increased fibrotic changes in their vein walls, like higher levels of certain proteins associated with injury, 8 days after experiencing a blood clot. This matters because understanding the role of CCR7 could help improve recovery from vein injuries and prevent complications for patients with DVT. Who this helps: Patients recovering from deep vein thrombosis.

Plain English
This study looked at how well surgical treatments work for patients with moderate to severe post-thrombotic syndrome (PTS), which can affect 5% to 10% of people after a blood clot in the leg. They found that 11 out of 12 studies showed improvements in symptoms and healing of leg ulcers after surgery, with healing rates between 50% and 100%. Although these findings are promising, the study also noted the need for more rigorous research due to some limitations in the reviewed studies. Who this helps: This helps patients suffering from moderate to severe PTS.

Plain English
This study looked at how consistently duplex ultrasound tests can detect venous reflux, a condition affecting blood flow in veins. Researchers found that tests performed in the morning with patients standing produced the most reliable results, with agreement between test results reaching 93.4% when a specific measure of 0.5 seconds was used. This consistency is crucial because it means doctors can trust the test results more, leading to better patient care. Who this helps: Patients with venous diseases benefit from more reliable testing and diagnosis.

Plain English
This study looked at a medical procedure called subintimal angioplasty (SA) used to treat severe blockages in the arteries of the leg. Researchers examined 120 patients and found that the procedure successfully opened the blocked arteries 91% of the time, with 90% of patients avoiding amputation after one year, and a remarkable 98% keeping their limbs. This matters because SA can be a safer option for patients who are at high risk for more complicated surgeries. Who this helps: This helps patients with severe leg artery blockages and their doctors.

Plain English
This study looked at how well a gene therapy called NV1FGF works when injected into the muscles of patients with a severe condition called critical limb ischemia, which often leads to amputation. In six patients, three different doses of the NV1FGF plasmid were injected before planned amputations. Results showed that the gene therapy effectively expressed the FGF-1 protein in the injected muscles, with the gene being present in an area of about 5-12 cm, and FGF-1-producing cells found within 3 cm of the injection sites. Who this helps: This research benefits patients with critical limb ischemia by exploring new treatment options that may enhance blood flow and potentially reduce the need for amputations.

Plain English
This research looked at how effective ultrasound-accelerated thrombolysis is for treating deep vein thrombosis (DVT) by reviewing 53 cases across eight centers in the United States. The study found that 70% of patients had complete clot removal, and 91% showed some degree of clot breakdown. This method not only improved the effectiveness of treatment but also reduced bleeding complications, with only two patients experiencing minor issues. Who this helps: Patients with deep vein thrombosis.

Plain English
This study looked at how well hospitals followed guidelines for preventing blood clots (venous thromboembolism, or VTE) in high-risk surgical patients. Out of nearly 1,900 patients, 89.3% received some form of clot prevention, but only 50.3% of those undergoing high-risk abdominal surgery received the best level of care recommended. This matters because improper use of these guidelines means many patients are at risk for serious complications like blood clots. Who this helps: This helps patients undergoing high-risk surgeries and their doctors.

Plain English
This study looked at various antiplatelet medications, including aspirin, ticlopidine, and clopidogrel, to determine their effectiveness and safety for preventing serious blood flow problems in patients with conditions like heart disease or prior strokes. The researchers found that clopidogrel is the preferred choice for people with peripheral artery disease, while either clopidogrel or aspirin is recommended for those who've had a heart attack or stroke, depending on individual circumstances. These findings matter because they provide clear guidelines for doctors on how to choose the best medication to prevent future cardiovascular incidents, potentially improving patient outcomes. Who this helps: This helps patients with atherosclerotic vascular disease.

Plain English
This study explored a noninvasive test called the venous filling index (VFI) to detect "critical" deep venous reflux, which is a serious condition affecting blood flow in the legs. The researchers found that a VFI score above 7 accurately identified critical venous reflux with 73% sensitivity and a perfect 100% positive predictive value. This matters because it could lead to better screening for patients at risk of severe venous issues, helping to prevent complications. Who this helps: Patients with venous insufficiency and their doctors.

Plain English
The study focused on using a high dose of a drug called streptokinase quickly in heart attack patients to dissolve blood clots. In this research, 13 patients received a large amount of streptokinase within 6 hours of their symptoms starting, and 6 of them had successful clot dissolving within just 1 hour. The results show that this method can effectively open blocked arteries in heart attacks without causing significant bleeding, which is important for improving heart function. Who this helps: This benefits patients experiencing heart attacks and their doctors by offering a quicker treatment option.